Rezolute, Inc. (DUS:6HV1) Financings

Rezolute, Inc.

Financings

RaiseDate
Public offering of common stock and pre-funded warrants
Announced: about US$100M · US$3.87 a share · Morgan Stanley +6
Dealers: Morgan Stanley (co-lead), Guggenheim Securities (co-lead), Cantor (co-lead), H.C. Wainwright & Co., Jones, Maxim Group LLC, Lake Street Capital Markets, LLC
Buyers: Frazier Life Sciences
Use of proceeds: Ersodetug commercialization preparation, working capital and general corporate purposes
Nov 13, 2026
Public offering of common stock and pre-funded warrants
Closed: US$96.9M raised · US$3.25 a share · Guggenheim Securities +6
Dealers: Guggenheim Securities (lead), BTIG (co-lead), H.C. Wainwright & Co. (co-lead), Jones (co-lead), Craig-Hallum, Maxim Group LLC, WG Partners LLP
Buyers: Federated Hermes Kaufmann Funds; Blackstone Multi-Asset Investing; Great Point Partners, LLC; Marshall Wace; Woodline Partners LP; Nantahala Capital; Squadron Capital Management
Use of proceeds: Research and development, general corporate expenses and working capital needs
Apr 25, 2025
Private placement of shares of common stock
Announced: up to US$4.2M
Apr 25, 2025

Read by 6ix AI from the company's releases